Zurueck zur Suche

Reporte zur Charge U01533

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

1Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 1

VAERS 2305002

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U01533

moderat
Staat
MI
Alter
71,0
Geschlecht
F
Eingang
01.06.2022
Impfdatum
19.12.2021
Beginn
22.05.2022
Tage bis Beginn
154,0
Dosis
N/A
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute kidney injury Blood creatinine increased Blood folate normal Blood iron decreased COVID-19 Chronic obstructive pulmonary disease Clostridium test negative Dehydration Diarrhoea Gastrointestinal pathogen panel Gastrooesophageal reflux disease Haemoglobin decreased Hyperlipidaemia Hypertension Iron deficiency anaemia Malaise Respiratory tract congestion Restless legs syndrome

Symptomtext

Discharge Provider: DO Primary Care Provider at Discharge: DO Admission Date: 5/22/2022 Discharge Date: 5/25/2022 HOSPITAL PROBLEMS 1. Covid-19 Infection 2. Diarrhea secondary to Covid-19 3. AKI 4. HTN 5. T2DM 6. IDA 7. COPD 8. GERD 9. HLD 10. RLS HOSPITAL COURSE: Patient is a 72 y.o. female admitted to hospital due to diarrhea and dehydration secondary to Covid-19 infection. Covid-19/Diarrhea: Patient admitted with several days of copious diarrhea and subsequent dehydration. She had also been feeling generally unwell, with congestion and rhinorrhea. Was found to be Covid positive on 5/22/2022. Did not have SOB, fever or cough. Was not candidate for steroids or Remdesivir. While thought diarrhea due to Covid infection did not want to overlook bacterial cause so enteric pathogens and C diff were tested which came back negative. Patient was started on IV fluids. Diarrhea began to resolve and patient was tolerating diet. Was able to discharge home. AKI: On admission Cr 3.32, with baseline 1.0-1.3. Likely prerenal given GI losses and dehydration. Lisinopril and Maxide was held, and she was started on IV fluids, with subsequent improvement in Cr. IV fluids were discontinued when patient had adequate PO intake, and Cr continued to show improvement. Was deemed stable for discharge home with follow up with PCP. Lisinopril and Maxide held at discharge, with repeat BMP ordered for 5/27/2022. IDA: Patients Hb 8.5 on admission. Vit B12 and folate WNL. Iron low at 26. Was started on Iron supplementation. EGD 2019: distal stricture with erosion, moderate HH. Colon 2017: 5 mm, diminutive polyp - tubular adenoma

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dehydration
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 12/13/2021 Discharge Date: 12/14/2021 PRESENTING PROBLEM: Cough, diarrhea, dizziness. See H&P from 12/13/21 for full details ED-Sepsis with tachycardia, tachypnea, leukocytosis and fever. CTA neg for PE. Rapid flu and covid negative. UA high spec gravity, non infectious. Started on abx to cover for CAP, film array pending. Mag low, repleted. HOSPITAL COURSE: Patient was admitted to the general medicine service for sepsis secondary to what was suspected to be community-acquired pneumonia versus viral upper respiratory infection. CTA thorax negative for PE, did have hazy bilateral lung opacities. She had no lactic acidosis, mild leukocytosis of 12k however her procalcitonin was wnl. She was initially started on Rocephin and Zithromax, her film array did return positive for human metapneumovirus. Her rocephin was discontinued as likely the source of her sepsis was the metapneumovirus and picture of dehydration on admission. She continues have diarrhea, stool studies were obtained prior to discharge, these are pending and she can follow this up with her PCP. We did ask that she hold her blood pressure medication including her backside for 2 days or until her diarrhea improves; she is normotensive today (home antihypertensives held) but did have soft blood pressures on admission which improved after she received 2 L of IV fluids in the emergency department. She will be prescribed 3 days of Zithromax given her possible bronchitis and hx of copd. She was not wheezing this admission so steroids were not started. Tessalon perles prescribed. She can continue to use her home albuterol mdi prn shortness of breath Sputum cx, strep pneumoniae and legionella studies pending at discharge Repeat A1C was obtained and pending. Blood sugars were stable while inpatient and did not require corrective insulin. She should follow up with PCP in about one week.
Vorgeschichte
COPD (chronic obstructive pulmonary disease) Type 2 diabetes mellitus, without long-term current use of insulin GERD (gastroesophageal reflux disease) Anxiety RLS (restless legs syndrome) Chest pain Infection due to human metapneumovirus (hMPV) COVID-19 virus infection High cholesterol Essential hypertension, benign AKI (acute kidney injury)
Andere Medikamente
albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler benzonatate (TESSALON) 100 MG capsule ferrous sulfate 325 (65 Fe) MG tablet fluorouracil (EFUDEX) 5 % cream fluticasone (FLONASE) 50 MCG/ACT nasal spr
Allergien
None
Vorherige Impfungen
-